219 related articles for article (PubMed ID: 29432761)
1. Application of the Quality by Design Approach to the Freezing Step of Freeze-Drying: Building the Design Space.
Arsiccio A; Pisano R
J Pharm Sci; 2018 Jun; 107(6):1586-1596. PubMed ID: 29432761
[TBL] [Abstract][Full Text] [Related]
2. Fast freeze-drying cycle design and optimization using a PAT based on the measurement of product temperature.
Bosca S; Barresi AA; Fissore D
Eur J Pharm Biopharm; 2013 Oct; 85(2):253-62. PubMed ID: 23631849
[TBL] [Abstract][Full Text] [Related]
3. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying.
Martini A; Kume S; Crivellente M; Artico R
PDA J Pharm Sci Technol; 1997; 51(2):62-7. PubMed ID: 9146035
[TBL] [Abstract][Full Text] [Related]
4. Freeze-drying using vacuum-induced surface freezing.
Kramer M; Sennhenn B; Lee G
J Pharm Sci; 2002 Feb; 91(2):433-43. PubMed ID: 11835203
[TBL] [Abstract][Full Text] [Related]
5. Freeze-drying process design by manometric temperature measurement: design of a smart freeze-dryer.
Tang XC; Nail SL; Pikal MJ
Pharm Res; 2005 Apr; 22(4):685-700. PubMed ID: 15889467
[TBL] [Abstract][Full Text] [Related]
6. Gap-freezing approach for shortening the lyophilization cycle time of pharmaceutical formulations-demonstration of the concept.
Kuu WY; Doty MJ; Rebbeck CL; Hurst WS; Cho YK
J Pharm Sci; 2013 Aug; 102(8):2572-88. PubMed ID: 23728733
[TBL] [Abstract][Full Text] [Related]
7. Investigation of design space for freeze-drying: use of modeling for primary drying segment of a freeze-drying cycle.
Koganti VR; Shalaev EY; Berry MR; Osterberg T; Youssef M; Hiebert DN; Kanka FA; Nolan M; Barrett R; Scalzo G; Fitzpatrick G; Fitzgibbon N; Luthra S; Zhang L
AAPS PharmSciTech; 2011 Sep; 12(3):854-61. PubMed ID: 21710335
[TBL] [Abstract][Full Text] [Related]
8. Through-vial impedance spectroscopy of critical events during the freezing stage of the lyophilization cycle: the example of the impact of sucrose on the crystallization of mannitol.
Arshad MS; Smith G; Polygalov E; Ermolina I
Eur J Pharm Biopharm; 2014 Aug; 87(3):598-605. PubMed ID: 24825125
[TBL] [Abstract][Full Text] [Related]
9. Modeling of heat and mass transfer processes for the gap-lyophilization system using the mannitol-trehalose-NaCl formulation.
Kuu WY; Doty MJ; Nisipeanu E; Rebbeck CL; Cho YK; Smit MH
J Pharm Sci; 2014 Sep; 103(9):2784-2796. PubMed ID: 24648334
[TBL] [Abstract][Full Text] [Related]
10. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulations.
Hawe A; Friess W
Eur J Pharm Biopharm; 2006 Nov; 64(3):316-25. PubMed ID: 16875806
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of the freezing stage in a freeze-drying process using IR thermography.
Colucci D; Maniaci R; Fissore D
Int J Pharm; 2019 Jul; 566():488-499. PubMed ID: 31175990
[TBL] [Abstract][Full Text] [Related]
12. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
13. Controlled nucleation in freeze-drying: effects on pore size in the dried product layer, mass transfer resistance, and primary drying rate.
Konstantinidis AK; Kuu W; Otten L; Nail SL; Sever RR
J Pharm Sci; 2011 Aug; 100(8):3453-3470. PubMed ID: 21465488
[TBL] [Abstract][Full Text] [Related]
14. Considerations on Protein Stability During Freezing and Its Impact on the Freeze-Drying Cycle: A Design Space Approach.
Arsiccio A; Giorsello P; Marenco L; Pisano R
J Pharm Sci; 2020 Jan; 109(1):464-475. PubMed ID: 31647953
[TBL] [Abstract][Full Text] [Related]
15. LyoPRONTO: an Open-Source Lyophilization Process Optimization Tool.
Shivkumar G; Kazarin PS; Strongrich AD; Alexeenko AA
AAPS PharmSciTech; 2019 Oct; 20(8):328. PubMed ID: 31673810
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of Controlled Ice Nucleation Techniques for Freeze-Drying of a Therapeutic Antibody.
Gitter JH; Geidobler R; Presser I; Winter G
J Pharm Sci; 2018 Nov; 107(11):2748-2754. PubMed ID: 30055225
[TBL] [Abstract][Full Text] [Related]
17. Mannitol as an Excipient for Lyophilized Injectable Formulations.
Thakral S; Sonje J; Munjal B; Bhatnagar B; Suryanarayanan R
J Pharm Sci; 2023 Jan; 112(1):19-35. PubMed ID: 36030846
[TBL] [Abstract][Full Text] [Related]
18. Impact of Ice Morphology on Design Space of Pharmaceutical Freeze-Drying.
Goshima H; Do G; Nakagawa K
J Pharm Sci; 2016 Jun; 105(6):1920-1933. PubMed ID: 27238489
[TBL] [Abstract][Full Text] [Related]
19. Lyophilization Cycle Design for Dual Chamber Cartridges and a Method for Online Process Control: The "DCC LyoMate" Procedure.
Korpus C; Friess W
J Pharm Sci; 2017 Aug; 106(8):2077-2087. PubMed ID: 28479354
[TBL] [Abstract][Full Text] [Related]
20. Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.
Izutsu KI
Adv Exp Med Biol; 2018; 1081():371-383. PubMed ID: 30288720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
